Zimmer, Inc.

Zimmer Biomet received Japan PMDA approval for the iTaperloc Complete and iG7 Hip System, marking the world's first approved orthopedic implants with iodine technology designed to inhibit bacterial adhesion and prevent biofilm formation.

NeuroOne Medical Technologies received FDA 510(k) clearance for its OneRF trigeminal nerve ablation system, marking the company's first expansion into chronic pain management.

Zimmer Biomet has received CE Mark certification for its RibFix Advantage Fixation System, marking the first CE Mark approval for an intrathoracic rib fixation system.

• Zimmer Biomet has received FDA 510(k) clearance for Persona Revision SoluTion Femur, the first metal alternative knee revision implant for patients with sensitivities to common metal allergens like nickel, cobalt, and chromium. • The implant utilizes proprietary Tivanium alloy with Ti-Nidium Surface Hardening Process, providing comparable hardness to traditional metal implants while enhancing wear performance and reducing particle release. • Metal hypersensitivity affects 10-15% of the general population and up to 25% of patients with metallic implants, potentially causing inflammatory responses, pain, and implant loosening requiring revision procedures.

Zimmer Biomet's Oxford Cementless Partial Knee receives FDA approval, offering improved fixation and long-term implant survival compared to cemented procedures.

THINK Surgical received FDA 510(k) clearance for its TMINI robotic system to be used with Zimmer Biomet's Persona Knee System, expanding surgical options.